Displaying all 6 publications

Abstract:
Sort:
  1. Roche GC, Fung P, Ransing R, Noor IM, Shalbafan M, El Hayek S, et al.
    Asia Pac Psychiatry, 2021 Mar;13(1):e12432.
    PMID: 33145988 DOI: 10.1111/appy.12432
    INTRODUCTION: This study aims to review recent scientific publications and research output in the field of psychiatry, from a series of countries in the Asia-Pacific region (Australia, India, Indonesia, Iran, Lebanon, Malaysia, and Nepal), with a view to identify themes and similarities across regions, as well as to examine the barriers and challenges in mental health research faced by countries in the region.

    METHODS: Seven psychiatrists from seven countries reviewed recent published and ongoing research in psychiatry in their respective nations, with respect to themes, as well as any barriers or challenges faced by mental health researchers.

    RESULTS: While the seven nations included in this review vary in terms of research capabilities and economic development level, they share many similarities both in terms of research direction, and with regards to challenges faced. Limitations in the form of sociocultural differences from the West, and a lack of funding were some of the barriers identified.

    DISCUSSION: Mental health research in the region has been progressing well. However, more varied research in the form of qualitative or economic studies are lacking, as are multi-center studies. The similar issues that nations face with regards to research could perhaps benefit from collaborative efforts and initiatives for the furtherance of research in the region.

  2. Ransing R, Vadivel R, Halabi SE, Jatchavala C, Shalbafan M, Noël C, et al.
    Indian J Psychol Med, 2023 Jan;45(1):65-68.
    PMID: 36778626 DOI: 10.1177/02537176211052071
  3. Ransing R, Koh EBY, Ramalho R, de Filippis R, Pinto da Costa M, Pereira-Sanchez V, et al.
    Front Psychiatry, 2023;14:1230059.
    PMID: 37692313 DOI: 10.3389/fpsyt.2023.1230059
  4. Kamalzadeh L, de Filippis R, El Hayek S, Heidari Mokarar M, Jatchavala C, Koh EBY, et al.
    Front Psychiatry, 2023;14:1307277.
    PMID: 38193134 DOI: 10.3389/fpsyt.2023.1307277
  5. Ransing R, de la Rosa PA, Pereira-Sanchez V, Handuleh JIM, Jerotic S, Gupta AK, et al.
    PMID: 34735077 DOI: 10.47626/2237-6089-2021-0263
    INTRODUCTION: Varying public views on cannabis use across countries may explain the variation in the prevalence of use, policies and research in individual countries, and global regulation of cannabis. This paper aims to describe the current state of cannabis use, policies, and research across sixteen countries.

    METHODS: PubMed and Google Scholar were searched for published studies from 2010 to 2020. Searches were conducted by using the relevant country of interest as a search term (e.g. "Iran"), as well as relevant predefined keywords such as "cannabis", "marijuana", "hashish", "bhang "dual diagnosis", "use", "addiction", "prevalence", "co-morbidity", "substance use disorder", "legalization" or "policy" (English and non-English). These keywords were used in multiple combinations to create the search string in studies records' titles and abstracts. Official websites of respective governments and international organizations were also searched in English and non-English (national language country) languages to identify the current state of cannabis use, policies, and research in each of those countries.

    RESULTS: Inconsistent and heterogeneous reporting of cannabis use, variation in policies (e.g., legalization), and intervention strategies across the reviewed countries were the main findings. European countries have dominated cannabis research output in PubMed, as compared to Asian countries (Thailand, Malaysia, India, Iran and Nepal).

    CONCLUSIONS: Although global cannabis regulation is ongoing, the existing heterogeneities across countries in terms of policies and epidemiology can increase the burden of cannabis use disorders disproportionately and unpredictably. There is an urgent need to develop global strategies to address these cross-country barriers to improve early detection, prevention, and interventions for cannabis use and related disorders.

  6. Scheibein F, Stowe MJ, Arya S, Morgan N, Shirasaka T, Grandinetti P, et al.
    Front Psychiatry, 2021;12:634309.
    PMID: 33796034 DOI: 10.3389/fpsyt.2021.634309
Related Terms
Filters
Contact Us

Please provide feedback to Administrator ([email protected])

External Links